Tat V - Search Results

1

Spatiotemporal Study of Galactolipid Biosynthesis in Duckweedwith Mass Spectrometry Imaging and in vivo Isotope Labeling.

Tat VT, Lee YJ. Tat VT, et al. Plant Cell Physiol. 2024 Apr 9:pcae032. doi: 10.1093/pcp/pcae032. Online ahead of print. Plant Cell Physiol. 2024. PMID: 38590126

2

Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.

GBD 2021 Fertility and Forecasting Collaborators. GBD 2021 Fertility and Forecasting Collaborators. Lancet. 2024 Mar 19:S0140-6736(24)00550-6. doi: 10.1016/S0140-6736(24)00550-6. Online ahead of print. Lancet. 2024. PMID: 38521087 Free article.

3

Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.

GBD 2021 Nervous System Disorders Collaborators. GBD 2021 Nervous System Disorders Collaborators. Lancet Neurol. 2024 Apr;23(4):344-381. doi: 10.1016/S1474-4422(24)00038-3. Epub 2024 Mar 14. Lancet Neurol. 2024. PMID: 38493795 Free PMC article.

4

Generation of a humanized mAce2 and a conditional hACE2 mouse models permissive to SARS-COV-2 infection.

Song IW, Washington M, Leynes C, Hsu J, Rayavara K, Bae Y, Haelterman N, Chen Y, Jiang MM, Drelich A, Tat V, Lanza DG, Lorenzo I, Heaney JD, Tseng CK, Lee B, Marom R. Song IW, et al. Among authors: tat v. Mamm Genome. 2024 Mar 15. doi: 10.1007/s00335-024-10033-8. Online ahead of print. Mamm Genome. 2024. PMID: 38488938

5

Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.

GBD 2021 Demographics Collaborators. GBD 2021 Demographics Collaborators. Lancet. 2024 Mar 8:S0140-6736(24)00476-8. doi: 10.1016/S0140-6736(24)00476-8. Online ahead of print. Lancet. 2024. PMID: 38484753 Free article.

6

An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations.

Westberg M, Su Y, Zou X, Huang P, Rustagi A, Garhyan J, Patel PB, Fernandez D, Wu Y, Hao C, Lo CW, Karim M, Ning L, Beck A, Saenkham-Huntsinger P, Tat V, Drelich A, Peng BH, Einav S, Tseng CK, Blish C, Lin MZ. Westberg M, et al. Among authors: tat v. Sci Transl Med. 2024 Mar 13;16(738):eadi0979. doi: 10.1126/scitranslmed.adi0979. Epub 2024 Mar 13. Sci Transl Med. 2024. PMID: 38478629

7

Protective Efficacy of Novel Engineered Human ACE2-Fc Fusion Protein Against Pan-SARS-CoV-2 Infection In Vitro and in Vivo.

Yu B, Drelich A, Hsu J, Tat V, Peng BH, Wei Q, Wang J, Wang H, Wages J, Mendelsohn AR, Larrick JW, Tseng CT. Yu B, et al. Among authors: tat v. J Med Chem. 2023 Dec 28;66(24):16646-16657. doi: 10.1021/acs.jmedchem.3c01201. Epub 2023 Dec 15. J Med Chem. 2023. PMID: 38100534

8

Global burden of chronic respiratory diseases and risk factors, 1990-2019: an update from the Global Burden of Disease Study 2019.

GBD 2019 Chronic Respiratory Diseases Collaborators. GBD 2019 Chronic Respiratory Diseases Collaborators. EClinicalMedicine. 2023 May;59:101936. doi: 10.1016/j.eclinm.2023.101936. EClinicalMedicine. 2023. PMID: 37229504 Free PMC article.

9

A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta.

Carter B, Huang P, Liu G, Liang Y, Lin PJC, Peng BH, McKay LGA, Dimitrakakis A, Hsu J, Tat V, Saenkham-Huntsinger P, Chen J, Kaseke C, Gaiha GD, Xu Q, Griffiths A, Tam YK, Tseng CK, Gifford DK. Carter B, et al. Among authors: tat v. Front Immunol. 2023 Mar 9;14:1135815. doi: 10.3389/fimmu.2023.1135815. eCollection 2023. Front Immunol. 2023. PMID: 36969239 Free PMC article.

10

Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026.

Global Burden of Disease 2021 Health Financing Collaborator Network. Global Burden of Disease 2021 Health Financing Collaborator Network. Lancet Glob Health. 2023 Mar;11(3):e385-e413. doi: 10.1016/S2214-109X(23)00007-4. Epub 2023 Jan 24. Lancet Glob Health. 2023. PMID: 36706770 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33 results

Search Page